Peter Wehrwein

The retail giant is teaming up with Clover Health to market Medicare Advantage plans in eight counties in Georgia.

This episode of Tuning Into The C-Suite welcomes our first of many episodes part of the new “Meet the Board” podcast series. Listeners will now hear from a member of Managed Healthcare Executive's Editorial Advisory Board once a month at the end of each month. The first guest featured is Physician and former Executive VP of the American Cancer Society, Otis Brawley. Brawley is a Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University.

Penn’s Amol Navathe, M.D., Ph.D., and colleagues reported favorable results in Health Affairs. Navathe is featured in this second of a two part video series.

Researchers compare beneficiaries with end-stage renal disease in a Medicare Advantage Special Needs Plan sponsored by CareMore to patients in traditional Medicare, explains Amol Navathe, M.D., Ph.D., an assistant professor in the Department of Medical Ethics and Health Policy at University of Pennsylvania’s Perelman School of Medicine, in this first of two part video series.

CMS is taking prior authorization for frequent, non-emergency ambulance transportation nationwide and launching a model that pay ambulance services for taking patients to nonhospital facilities.

A study conducted in China during the early weeks of the pandemic found few eyeglass wearers among hospitalized COVID-19 cases.

Researchers identify steep decline in angioplasties at investigated hospitals.

The leverage of "must-have" hospitals is one explanation for high relative prices. The researchers said private payers should support policies that encourage competition and fend off consolidation among payers.

The pandemic has had dramatically different consequences for the finances of payers and providers.

Patient navigators, following an algorithm and using telephone calls to contact patients, improved ACE inhibitor and beta blocker usage among heart failure patients.

Drugs block the formation of tiny blood vessels in the retina that are prone to breaking open, resulting in bleeds that can cause serious vision impairment and blindness, explains ADA chief scientific and medical officer, Robert Gabbay, in this conclusion of a four-part video series.

Emory University researchers found that financial toxicity may be a more serious problem for multiple sclerosis patients than for cancer patients.

Less than half of Americans with diabetes get annual eye exams, says Robert Gabbay, M.D.,Ph.D., FACP, in this third of a four-part video series. Gabbay became chief scientific and medical officer for the American Diabetes Association this summer.

In this second of a four-part video series, ADA Chief Science and Medical Officer Robert Gabbay, MD, PhD, FACP, says data showing kidney benefits of SGLT2 inhibitors may indicate protection against retinopathy but research is needed.

The American Diabetes Association and other groups are mounting a public health campaign to encourage people with diabetes to get annual eye exams. ADA Chief Scientific and Medical Officer Robert Gabbay, MD, PhD, FACP, explains "leaky blood vessels" and diabetic retinopathy in this first of a four-part video series.

The symptoms of the adverse event that led to the pause in Astra Zeneca's COVID-19 vaccine trial are reportedly consistent with transverse myelitis. although the diagnosis has not been confirmed.

Brent James discusses the long-term consequences of COVID-19.

Brent James, M.D., M.Stat., the quality and patient safety expert, finds fault with singular focus on COVID-19. Watch James' interview in this part two of three video series.

Brent James, the quality and patient safety expert, sees excess mortality from lack of care for life-threatening conditions other than COVID-19. Watch James' interview in this part one of three video series.

Founders of Medicaid had reason to fear that a state-run program would have limited ability to address the needs of vulnerable populations, say authors of Health Affairs piece.

This week on Tuning Into the C-Suite, Managed Healthcare Executive's Senior Editor, Peter Wehrwein, spoke with Georgetown's Sabrina Corlette, JD. The two discussed the possible motivations behind health insurer announcing premium credits and discounts in recent weeks and months after their profits (net income, for not-for-profits) swelled due to the drop-off in routine healthcare utilization.

deCODE Genetics researchers find that 90% of those diagnosed with SARS-CoV-2 infection have antibodies to the virus four months later.

Georgetown’s Sabrina Corlette says the 2021 rates were calculated before the recent announcements about COVID-19 premium relief in this part two of two video series.

Georgetown’s Sabrina Corlette explains some of the motivations behind the spate of premium credits and discounts from health insurers in this part one of two series.

Kaufman Hall's Jim Blake says favorable numbers may just be "the calm before the storm."

Senior Editor Peter Wehrwein speaks with Lou Ellen Horwitz, CEO of the Urgent Care Association, in this part two of two video series about centers that have not been paid yet for tests.

Blue Cross and Blue Shield of Minnesota is among the health insurers giving businesses and individuals a break on premiums.

Senior Editor Peter Wehrwein speaks with Lou Ellen Horwitz, CEO of th eUrgent Care Association, about how urgent care centers struggled to personal protective equipment and access to testing.